| Literature DB >> 30959972 |
Myriam D Jeninga1, Jennifer E Quinn2, Michaela Petter3,4.
Abstract
Apicomplexan parasites are protozoan organisms that are characterised by complex life cycles and they include medically important species, such as the malaria parasite Plasmodium and the causative agents of toxoplasmosis (Toxoplasma gondii) and cryptosporidiosis (Cryptosporidium spp.). Apicomplexan parasites can infect one or more hosts, in which they differentiate into several morphologically and metabolically distinct life cycle stages. These developmental transitions rely on changes in gene expression. In the last few years, the important roles of different members of the ApiAP2 transcription factor family in regulating life cycle transitions and other aspects of parasite biology have become apparent. Here, we review recent progress in our understanding of the different members of the ApiAP2 transcription factor family in apicomplexan parasites.Entities:
Keywords: ApiAP2; Apicomplexa; Cryptosporidium; Plasmodium; Toxoplasma; differentiation; gene regulation; malaria; transcription factor
Year: 2019 PMID: 30959972 PMCID: PMC6631176 DOI: 10.3390/pathogens8020047
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1Apicomplexan AP2 (ApiAP2)-domain-containig proteins in P. falciparum. The proteins are organised by size, ApiAP2-domains are marked in red, ACDC (AP2-coincident domain mainly at the C-terminus) domains in pink, AT hooks in black, zinc finger in blue, Acyl-CoA-N-acyltransferase in light blue, pentapeptide-repeat-like domains in yellow.
Figure 2Simplified schematic life cycle depicting major developmental transitions during apicomplexan parasite development, which involve regulation by ApiAP2 transcription factors (TFs).
ApiAP2 TFs in Plasmodium spp.
| Name | Ortholog in | Ortholog in | Ortholog in | Mutated in | Disrupted in | Disrupted in | Phenotype (-| Block) | Motif Recognized [ | Further Ref | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PF3D7_0404100 | AP2-SP2 | PVX_001040 | PBANKA_1001800 | PY17X_1003200 | yes | yes [ | yes | oocyst -| sporoblast | ||
| 2 | PF3D7_0420300 | PVX_090110 | PBANKA_0521700 | PY17X_0523100 | refractory | refractory [ | yes | n.a. | CACACAC, GTGTTACAC | ||
| 3 | PF3D7_0516800 | AP2-O2 | PVX_080410 | PBANKA_1231600 | PY17X_1235000 | yes | yes [ | yes | zygote -| ookinete | TGACATCA | |
| 4 | PF3D7_0604100 | SIP2 | PVX_113370 | PBANKA_0102900 | PY17X_0104500 | yes | refractory [ | refractory | n.a. | GGTGCAC | [ |
| 5 | PF3D7_0611200 | PVX_113695 | PBANKA_0109500 | PY17X_0111100 | yes | yes [ | refractory | slow growth | |||
| 6 | PF3D7_0613800 | PVX_113825 | PBANKA_0112100 | PY17X_0113700 | refractory | refractory [ | refractory | n.a. | ATAAGCCCA, CTCTAGAG | ||
| 7 | PF3D7_0622900 | AP2-Tel/SP3 | PVX_114260 | PBANKA_1121800 | PY17X_1123200 | yes | yes [ | yes | sporozoites -| liver stage | [ | |
| 8 | PF3D7_0730300 | AP2-L | PVX_081810 | PBANKA_0214400 | PY17X_0215800 | yes | yes [ | refractory | sporozoites -| liver stage | AATTTCC | [ |
| 9 | PF3D7_0802100 | n.a. | PBANKA_1228100 | PY17X_1231600 | refractory | refractory [ | refractory | n.a. | CACACACA | ||
| 10 | PF3D7_0934400 | PVX_086995 | PBANKA_0835200 | PY17X_0838600 | refractory | refractory [ | refractory | n.a. | |||
| 11 | PF3D7_1007700 | AP2-I | PVX_094580 | PBANKA_1205900 | PY17X_1209100 | refractory | refractory [ | refractory | n.a. | GGGTCGACCC TCTTGCC GTGCACTA | [ |
| 12 | PF3D7_1107800 | PVX_091065 | PBANKA_0939100 | PY17X_0941600 | refractory | refractory [ | refractory | n.a. | AGCATAC | ||
| 13 | PF3D7_1115500 | PVX_091420 | PBANKA_0932300 | PY17X_0934300 | refractory | yes [ | refractory | n.a. | |||
| 14 | PF3D7_1139300 | PVX_092570 | PBANKA_0909600 | PY17X_0911000 | yes | refractory [ | refractory | n.a. | TAGAACAA | ||
| 15 | PF3D7_1143100 | AP2-O | PVX_092760 | PBANKA_0905900 | PY17X_0907300 | refractory | yes [ | yes | ookinete -| oocyst | TAGCTA [ | [ |
| 16 | PF3D7_1222400 | PVX_123750 | n.a. | n.a. | yes | n.a. | n.a. | n.a. | TATATATA | ||
| 17 | PF3D7_1222600 | AP2-G | PVX_123760 | PBANKA_1437500 | PY17X_1440000 | yes | yes [ | yes | asexual -| gametocyte | GxGTACxC [ | [ |
| 18 | PF3D7_1239200 | PVX_100910 | PBANKA_1453700 | PY17X_1456200 | refractory | refractory [ | refractory | n.a. | TCTA(C/T)AA | ||
| 19 | PF3D7_1305200 | PVX_122095 | PBANKA_1403700 | PY17X_1405400 | yes | refractory [ | refractory | n.a. | TGCACACAC | ||
| 20 | PF3D7_1317200 | AP2-G3 | PVX_122680 | PBANKA_1415700 | PY17X_1417400 | yes | refractory [ | yes | asexual -| gametocyte | TAGCTCA(G/A)A | [ |
| 21 | PF3D7_1342900 | PVX_083040 | PBANKA_1356000 | PY17X_1361700 | yes | refractory [ | refractory | n.a. | GCGGGGC | [ | |
| 22 | PF3D7_1350900 | AP2-O4 | PVX_083440 | PBANKA_1363700 | PY17X_1369400 | refractory | yes [ | yes | ookinete -| oocyst | ATTCTAGAA | [ |
| 23 | PF3D7_1408200 | AP2-G2 | PVX_086035 | PBANKA_1034300 | PY17X_1036700 | yes | yes [ | yes | asexual -| gametocyte | GTTG(T/C) [ | [ |
| 24 | PF3D7_1429200 | AP2-O3 | PVX_085085 | PBANKA_1015500 | PY17X_1017000 | yes | yes [ | yes | zygote -| ookinete | [ | |
| 25 | PF3D7_1449500 | AP2-O5 | PVX_118015 | PBANKA_1313200 | PY17X_1317000 | refractory | refractory [ | yes | zygote -| ookinete | ||
| 26 | PF3D7_1456000 | PVX_117665 | PBANKA_1319700 | PY17X_1323500 | yes | yes [ | yes | dispensable | CACACACAC | ||
| 27 | PF3D7_1466400 | AP2-SP/EXP | PVX_117145 | PBANKA_1329800 | PY17X_1334500 | yes | yes [ | refractory | oocyst -| sporoblast | TGCATGCA | [ |
| 28 | n.a. | AP2-Q | PVX_080355 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | [ |
ApiAP2 TFs in T. gondii.
| AP2 | Name | Function/Phenotype | Interactions | |
|---|---|---|---|---|
| 1 | TGME49_208020 | AP2Ib-1 | ||
| 2 | TGME49_252370 | AP2III-1 | ||
| 3 | TGME49_253380 | AP2III-2 | ||
| 4 | TGME49_299150 | AP2III-3 | ||
| 5 | TGME49_299020 | AP2III-4 | ||
| 6 | TGME49_320700 | AP2IV-1 | ||
| 7 | TGME49_320680 | AP2IV-2 | ||
| 8 | TGME49_318610 | AP2IV-3 | Control of bradyzoite genes [ | |
| 9 | TGME49_318470 | AP2IV-4 | KO leads to expression of bradyzoite specific genes in tachyzoites [ | |
| 10 | TGME49_211720 | AP2IV-5 | ||
| 11 | TGME49_267460 | AP2IX-1 | ||
| 12 | TGME49_264485 | AP2IX-3 | ||
| 13 | TGME49_288950 | AP2IX-4 | KO leads to reduces tissue cyst formation [ | |
| 14 | TGME49_289710 | AP2IX-5 | ||
| 15 | TGME49_290180 | AP2IX-6 | ||
| 16 | TGME49_290630 | AP2IX-7 | Implicated in cell cycle progression to S-phase [ | GCN5b [ |
| 17 | TGME49_306000 | AP2IX-8 | ||
| 18 | TGME49_306620 | AP2IX-9 | KO enhances cyst formation, alkaline stress response [ | |
| 19 | TGME49_220530 | AP2V-1 | ||
| 20 | TGME49_285895 | AP2V-2 | ||
| 21 | TGME49_240460 | AP2VI-1 | ||
| 22 | TGME49_240900 | AP2VI-2 | ||
| 23 | TGME49_244510 | AP2VI-3 | ||
| 24 | TGME49_280470 | AP2VIIa-1 | ||
| 25 | TGME49_280460 | AP2VIIa-2 | ||
| 26 | TGME49_205650 | AP2VIIa-3 | ||
| 27 | TGME49_203710 | AP2VIIa-4 | ||
| 28 | TGME49_203690 | AP2VIIa-5 | ||
| 29 | TGME49_203050 | AP2VIIa-6 | Implicated in cell cycle progression to S-phase [ | |
| 30 | TGME49_202490 | AP2VIIa-7 | ||
| 31 | TGME49_282210 | AP2VIIa-8 | ||
| 32 | TGME49_282220 | AP2VIIa-9 | ||
| 33 | TGME49_262420 | APVIIb-1/ADA2-B | ||
| 34 | TGME49_262000 | AP2VIIb-2 | ||
| 35 | TGME49_255220 | AP2VIIb-3 | ||
| 36 | TGME49_229370 | AP2VIII-1 | ||
| 37 | TGME49_233120 | AP2VIII-2 | ||
| 38 | TGME49_273660 | AP2VIII-3 | ||
| 39 | TGME49_272710 | AP2VIII-4 | Implicated in cell cycle progression to S-phase [ | |
| 40 | TGME49_271200 | AP2VIII-5 | ||
| 41 | TGME49_271030 | AP2VIII-6 | ||
| 42 | TGME49_269010 | AP2VIII-7 | ||
| 43 | TGME49_227900 | AP2X-1 | ||
| 44 | TGME49_225110 | AP2X-2 | ||
| 45 | TGME49_224230 | AP2X-3 | ||
| 46 | TGME49_224050 | AP2X-4 | ||
| 47 | TGME49_237090 | AP2X-5 | Implicated in virulence gene regulation [ | AP2XI-5 [ |
| 48 | TGME49_237425 | AP2X-6 | ||
| 49 | TGME49_214840 | AP2X-7 | Implicated in cell cycle progression to S-phase [ | |
| 50 | TGME49_214960 | AP2X-8 | GCN5b [ | |
| 51 | TGME49_215150 | AP2X-9 | ||
| 52 | TGME49_215340 | AP2X-10 | ||
| 53 | TGME49_215570 | AP2X-11 | ||
| 54 | TGME49_309410 | AP2XI-1 | ||
| 55 | TGME49_310900 | AP2XI-2 | GCN5b [ | |
| 56 | TGME49_310950 | AP2XI-3 | ||
| 57 | TGME49_315760 | AP2XI-4 | KO inhibits cyst formation [ | |
| 58 | TGME49_216220 | AP2XI-5 | Implicated in virulence gene regulation [ | AP2X-5 [ |
| 59 | TGME49_215895 | AP2 domain-containing protein | ||
| 60 | TGME49_218960 | AP2XII-1 | ||
| 61 | TGME49_217700 | AP2XII-2 | ||
| 62 | TGME49_246660 | AP2XII-3 | ||
| 63 | TGME49_247700 | AP2XII-4 | Implicated in cell cycle progression to S-phase [ | GCN5b [ |
| 64 | TGME49_247730 | AP2XII-5 | ||
| 65 | TGME49_249190 | AP2XII-6 | ||
| 66 | TGME49_250800 | AP2XII-8 | ||
| 67 | TGME49_251740 | AP2XII-9 |